These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 15678814)

  • 1. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
    Singla R; Gupta S; Gupta R; Arora VK
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].
    Bekembaeva GS; Serikbaeva KS; Kastypkaeva DV
    Probl Tuberk Bolezn Legk; 2009; (6):13-6. PubMed ID: 19642567
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of drug susceptibility pattern and mycobacterial species in sputum smear positive pulmonary tuberculosis patients with and without HIV co-infection in north west Ethiopia.
    Mekonen M; Abate E; Aseffa A; Anagaw B; Elias D; Hailu E; Idh J; Moges F; Wolde-Amanuel Y; Asrat D; Yamuah L; Britton S; Stendahl O; Schön T
    Ethiop Med J; 2010 Jul; 48(3):203-10. PubMed ID: 21073081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multi-drug resistant lung tuberculosis due to double infection of MDR strain].
    Ito K; Takahashi M; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2004 Jun; 79(6):387-90. PubMed ID: 15293752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.
    Trollip AP; Moore D; Coronel J; Caviedes L; Klages S; Victor T; Romancenco E; Crudu V; Ajbani K; Vineet VP; Rodrigues C; Jackson RL; Eisenach K; Garfein RS; Rodwell TC; Desmond E; Groessl EJ; Ganiats TG; Catanzaro A
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):227-32. PubMed ID: 24429318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?
    Badoum G; Saleri N; Dembélé MS; Ouedraogo M; Pinsi G; Boncoungou K; Bonkoungou V; Birba E; Miotto P; Migliori GB; Cirillo DM; Matteelli A
    Eur Respir J; 2011 May; 37(5):1283-5. PubMed ID: 21532018
    [No Abstract]   [Full Text] [Related]  

  • 9. Infection due to a novel mycobacterium, mimicking multidrug-resistant Mycobacterium tuberculosis.
    Tortoli E; Rogasi PG; Fantoni E; Beltrami C; De Francisci A; Mariottini A
    Clin Microbiol Infect; 2010 Aug; 16(8):1130-4. PubMed ID: 19832722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of patients with chronic pulmonary tuberculosis with expectoration--evaluation of effectiveness].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):164-71. PubMed ID: 9489411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic marking of polyresistant mycobacterium tuberculosis strains isolated in the north-west of Russia].
    Narvskaia OV; Mokrousov IV; Otten TF; Vishnevskiĭ BI
    Probl Tuberk; 1999; (3):39-41. PubMed ID: 10420767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
    Mpagama SG; Ndusilo N; Stroup S; Kumburu H; Peloquin CA; Gratz J; Houpt ER; Kibiki GS; Heysell SK
    Antimicrob Agents Chemother; 2014; 58(2):782-8. PubMed ID: 24247125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide].
    Blanco Ramos JR; Rosel Rioja L; Dopereiro Gómez R; Oteo Revuelta JA
    An Med Interna; 1997 Aug; 14(8):433-4. PubMed ID: 9376493
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].
    Zhukova MP
    Probl Tuberk; 1997; (5):12-5. PubMed ID: 9454239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
    Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI
    Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain differentiation of Mycobacterium tuberculosis complex isolated from sputum of pulmonary tuberculosis patients.
    Abbadi S; El Hadidy G; Gomaa N; Cooksey R
    Int J Infect Dis; 2009 Mar; 13(2):236-42. PubMed ID: 18838283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spread of drug-resistant strains of mycobacterium tuberculosis among patients with isolated bacteria].
    Zhukova MP
    Probl Tuberk; 1998; (1):14-6. PubMed ID: 9553424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human multidrug-resistant Mycobacterium bovis infection in Mexico.
    Vazquez-Chacon CA; Martínez-Guarneros A; Couvin D; González-Y-Merchand JA; Rivera-Gutierrez S; Escobar-Gutierrez A; De-la-Cruz López JJ; Gomez-Bustamante A; Gonzalez-Macal GA; Gonçalves Rossi LM; Muñiz-Salazar R; Rastogi N; Vaughan G
    Tuberculosis (Edinb); 2015 Dec; 95(6):802-809. PubMed ID: 26299906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report.
    Berning SE; Cherry TA; Iseman MD
    Clin Infect Dis; 2001 Feb; 32(4):643-6. PubMed ID: 11181130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.